LATEST ALERTS
Cannabinoids
Anvisa authorises cannabis cultivation for research purposes…
19th December 2022 - Alerts | Brazil, South America |
Italy: CBD and cannabis regulation, December 2022
19th December 2022 - Regulatory reports |
This report provides a detailed overview of the current regulatory framework in place for CBD, hemp and cannabis, covering all policy areas
Executives acquitted of fraud relating to cannabis production…
16th December 2022 - Alerts | Canada, North America |
Germany: CBD and cannabis snapshot
15th December 2022 - Market reports , Regulatory reports |
This snapshot of Germany’s CBD and cannabis sector covers both the regulatory framework for CBD as well as cannabis (recreational and medical) and offers an overview of the market, online retailers and consumer preferences
Spain: CBD and cannabis snapshot
14th December 2022 - Market reports , Regulatory reports |
This snapshot of Spain’s CBD and cannabis sector covers both the regulatory framework for CBD as well as cannabis (recreational and medical) and offers an overview of the market, online retailers and consumer preferences
Medical Marijuana and Cannabidiol Research Expansion Act signed into law…
5th December 2022 - Alerts | North America, United States |
Global cannabinoid vape compliance guide
2nd December 2022 - Regulatory reports |
The cannabinoid vape compliance guide goes beyond the legality of cannabinoid-containing vaping products and provides regulatory information on how they can reach the market and thrive
Province lifts ban on some cannabis vapes…
2nd December 2022 - Alerts | Canada, North America |
Netherlands: CBD and cannabis snapshot
30th November 2022 - Market reports , Regulatory reports |
This snapshot of the Netherland’s CBD and cannabis sector covers both the regulatory framework for CBD as well as cannabis (recreational and medical) and offers an overview of the market, online retailers and consumer preferences
France: CBD and cannabis snapshot
29th November 2022 - Market reports , Regulatory reports |
This snapshot of France’s CBD and cannabis sector covers both the regulatory framework for CBD as well as cannabis (recreational and medical) and offers an overview of the market, online retailers and consumer preferences
Grey area over medical cannabis regime in Mexico leaves industry pessimistic
28th November 2022 - News analysis |
Members of the Mexican cannabis sector have told CannIntelligence they are pessimistic about whether the framework to regulate the national medical cannabis industry will be implemented before 2024
Tilray bets on cannabis-infused drinks, grows distribution network in the US
25th November 2022 - News analysis |
Tilray Brands continues to show signs of confidence in the future of cannabis-infused drinks by adding more beverage firms to its portfolio and building a distribution network
Lebanon: CBD and cannabis regulation, November 2022
24th November 2022 - Regulatory reports |
This report provides a detailed overview of the current regulatory framework in place in Lebanon for hemp, cannabinoids such as CBD, and cannabis
How will the midterm shift in the balance of power in Washington affect cannabis?
23rd November 2022 - News analysis |
The predicted Red Wave never arrived – but how have the prospects for cannabis-related federal legislation in the US been changed by the midterm elections? US correspondent James DeLise considers the new balance of power in Washington
UK FSA novel food process can succeed with ‘supportive and sensible approach’
21st November 2022 - News analysis |
A cannabis regulation lawyer believes the UK Food Standards Agency (FSA) and the CBD sector have invested so much time, effort and money in the novel food process that it cannot be allowed to fail
Biden to sign bill on medical cannabis and CBD research…
21st November 2022 - Alerts | North America, United States |
US Major League Baseball makes deal with CBD company Charlotte’s Web
18th November 2022 - News analysis |
In an exclusive partnership with Charlotte’s Web, Major League Baseball (MLB) has become the first of the major US sports leagues to sign a deal with a cannabinoid company
US medical cannabis and CBD research bill sent for presidential approval…
17th November 2022 - Alerts | North America, United States |
More validated but no light at the end of the tunnel for Efsa’s novel food applicants
16th November 2022 - News analysis |
Nearly six months after the European Food Safety Authority (Efsa) put novel food assessments for cannabinoids on hold, none of the validated applicants has been able to fill the identified knowledge gaps
Sweden’s turn to the right may have shut down hopes of liberalisation on cannabis
15th November 2022 - News analysis |
Sweden’s general election in September was not good news for cannabis advocates, with the new right-wing bloc minority government likely to take a highly restrictive view, while cannabinoids are not high on its agenda
US FDA to ‘advance efforts’ on cannabis research and law with new appointee
14th November 2022 - News analysis |
The US Food and Drug Administration (FDA) recently appointed Norman Birenbaum to a top post as a senior public health adviser in the FDA’s Center for Regulatory Programs, signalling a seismic shift at the agency
Netherlands: CBD and cannabis regulation, November 2022
11th November 2022 - Regulatory reports |
This report provides a detailed overview of the current regulatory framework in place in the Netherlands for hemp, cannabinoids such as CBD and cannabis
$0 to $7.8m in three months – tobacco firm cashes in on cannabis and hemp
9th November 2022 - News analysis |
US tobacco company 22nd Century Group has enjoyed its first full quarter benefitting from revenue generated by its new hemp/cannabis business arm
First licence is approved to cultivate hemp…
7th November 2022 - Alerts | Central America, Costa Rica |
Mexico cannabis industry doubtful of recreational bill approval before 2024
7th November 2022 - News analysis |
Legal hurdles impeding recreational cannabis legalisation in Mexico are expected to continue through 2024, industry members told CannIntelligence during the CannaMexico conference last month
OPH makes recommendations for Cannabis Act Review…
4th November 2022 - Alerts | Canada, North America |
The UDAF steps up enforcement efforts on synthetic and derivative cannabinoids…
4th November 2022 - Alerts | North America, United States, Utah |
Ambitious German startup puts its Signature on Ccell CBD vaping devices
3rd November 2022 - News analysis |
German hemp supplier Signature Products is taking a step back to its roots, saying it will step up its marketing of Ccell vape devices that can be filled with CBD extracts
Austria’s ‘Kafkaesque’ politics keep medical cannabis tied up in knots
1st November 2022 - News analysis |
Austria’s almost non-existent regime for the use of cannabinoids in medication has been described as “a Kafkaesque nightmare” with over-officious bureaucracy putting pointless hurdles in patients’ way
Brazil’s new president supports a new drug policy…
31st October 2022 - Alerts | Brazil, South America |
Amazon cannabinoid prohibition policy not strictly enforced on UK, US sites
28th October 2022 - News analysis |
Amazon still seems to be laissez-faire about enforcement of ingestible hemp-derived cannabinoid products that appear on its site – and in particular those containing intoxicating hemp-derived cannabinoids (IHDCs)
UK standards authority challenges CBD product marketing disguised as content
28th October 2022 - News analysis |
The UK Advertising Standards Authority (ASA) has taken action on CBD product marketing, targeting a series of advertorials produced by Consumer Logic Research specifically promoting two brands
Opposition party opposed to hemp THC content increase…
24th October 2022 - Alerts | South America, Suriname |
UK scientist says medicinal cannabis research in the country lagging behind
21st October 2022 - News analysis |
The UK is lagging behind other major markets in the world on research into the benefits of medicinal cannabis, according to a scientist specialising in the area
What the cannabis scheduling review means for the US
21st October 2022 - Regulatory reports |
US president Joe Biden has called for a scheduling review of cannabis. This report will examine the procedure, potential outcomes, and implications of this scheduling review.
Medical agency restricts use of CBD for cases of epilepsy only…
18th October 2022 - Alerts | Brazil, South America |
Agriculture secretary calls for proposals hemp projects…
18th October 2022 - Alerts | North America, Pennsylvania, United States |
Medical cannabis could come to Japan after panel recommends legalisation
17th October 2022 - News analysis |
Japan has taken a step closer to legalising cannabinoid-based medicines and clarifying restrictions on hemp cultivation, though it is also set to strengthen measures against recreational cannabis use
Malta: CBD and cannabis regulation, October 2022
6th October 2022 - Regulatory reports |
This report provides a detailed overview of the current regulatory framework in place for hemp, cannabinoids and cannabis, covering everything from processing and cultivation to finished products, import/export and the countries medical and recreational cannabis regime
